Biocompatible Coated Nanostructured Titanium Surfaces
Bioactive molecules have been coated on nanotubular structured titanium substrates by molecular plasma deposition. The coatings promote cell adhesion and are particularly suited for orthopedic implants that provide improved bone cell adhesion and new tissue growth. Nanodimensional features on titanium substrates are engineered using electrochemical anodization techniques. The nanostructured surfaces provide superior support for a wide selection of polypeptide coatings.
1 . A titanium or titanium alloy substrate coated with a molecular plasma deposited polypeptide wherein said substrate comprises a nanotubular structured surface.
2 . The nanotubular surface of claim 1 wherein the molecular plasma is generated from a colloidal suspension or solution of the polypeptide generated at high voltage as a charged molecular corona.
3 . The titanium alloy substrate of claim 1 wherein the titanium alloy is TiAlV, TiNi, TiAlNb, TiN, TiNbTaZr or Nitinol.
4 . The nanotubular surface of claim 1 wherein the nanotubes are about 40 nm to about 500 nm in diameter.
5 . The nanotubular surface of claim 4 wherein the nanotubes are about 70-130 nm in diameter.
6 . The nanotubular surface of claim 1 wherein the nanotubes are about 50-500 nm in length.
7 . The nanotubular surface of claim 1 wherein the deposited polypeptide is selected from RGDS (SEQ ID NO. 12); KRSR (SEQ ID NO. 6) and IKVAV (SEQ ID NO. 1) and combinations thereof.
8 . The nanotubular surface of claim 7 wherein the deposited polypeptide is RGDS.
9 . A method for promoting bone-forming cell adhesion to a substrate surface, comprising coating an anodized titanium surface with a molecular plasma deposited polypeptide selected from the group consisting of vitronectin, fibronectin, collagen, peptides SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO: 3, BSP, BMP-2, and OP-1; and exposing the coated substrate surface to osteoblast cells wherein the osteoblast cells adhere to the surface and are capable of proliferating under in vitro or in vivo conditions.
10 . The method of claim 9 wherein the polypeptide is RODS (SEQ ID No. 12); KRSR (SEQ NO. 6); IKVAV (SEQ ID NO. 1) or combinations thereof.
11 . The method of claim 9 wherein the polypeptide is a protein comprising the amino acid sequence of SEQ ID NO. 12 or SEQ ID NO. 6.
12 . The method of claim 9 wherein the anodized titanium surface comprises nanotubules having a diameter of about 40 up to about 120 nm.
13 . A nanotubular titanium surface coated with a peptide comprising the amino acid sequence RGD to which osteoblast cells are attached.
14 . A time-release bioactive material coated on a nanotubular titanium substrate wherein the bioactive material is non-covalently associated with the nanotubular landscape and releases with a t 1/2 of about 3 days.